Mechanism of vinorelbine-induced radiosensitization of human small cell lung cancer cells

Cancer Chemother Pharmacol. 2002 May;49(5):385-90. doi: 10.1007/s00280-002-0430-x. Epub 2002 Mar 2.

Abstract

Vinorelbine (Navelbine, KW-2307), a semisynthetic vinca alkaloid, is a potent inhibitor of mitotic microtubule polymerization. The aims of this study were to demonstrate vinorelbine-induced radiosensitization of human small cell lung cancer (SCLC) SBC-3 cells and to elucidate the mechanisms of radiosensitization. A clonogenic assay demonstrated that SBC-3 cells were sensitized to radiation by vinorelbine using different schedules combining exposure to both. The sensitizer enhancement ratios (SERs) at a cell survival level of 10% were 1.42+/-0.21 to 1.33+/-0.06, and 1.22+/-0.07 depending on schedule. Vinorelbine-induced radiosensitization did not depend on the schedule of the combined exposure. Flow cytometric analyses showed that the cells did not accumulate in the radiosensitive G(2)/M phase of the cell cycle after concurrent treatment with vinorelbine and radiation. The results of an alkaline filter elution assay demonstrated that in the presence of vinorelbine at 1 n M radiation-induced DNA strand breaks were not completely repaired at 24 h postradiation. We conclude that human SCLC SBC-3 cells are sensitized to radiation by vinorelbine and that a possible mechanisms of vinorelbine-induced radiosensitization may at least in part be associated with impairment of DNA repair following radiation-induced DNA damage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Small Cell / pathology
  • Carcinoma, Small Cell / radiotherapy*
  • Cell Cycle / drug effects
  • DNA Damage / drug effects
  • DNA Damage / radiation effects
  • DNA, Neoplasm / drug effects
  • DNA, Neoplasm / radiation effects
  • Flow Cytometry
  • Humans
  • Lung Neoplasms / pathology
  • Lung Neoplasms / radiotherapy*
  • Radiation-Sensitizing Agents / pharmacology*
  • Tumor Cells, Cultured
  • Tumor Stem Cell Assay
  • Vinblastine / analogs & derivatives*
  • Vinblastine / pharmacology*
  • Vinorelbine

Substances

  • DNA, Neoplasm
  • Radiation-Sensitizing Agents
  • Vinblastine
  • Vinorelbine